Literature DB >> 30327902

Research ethics aspects of experimentation with LSD on human subjects: a historical and ethical review.

Kristóf János Bodnár1, Péter Kakuk2.   

Abstract

In this paper our aim is to examine whether research conducted on human participants with LSD-25 (lysergic acid diethylamide) raises unique research ethical questions or demands particular concerns with regard to the design, conduct and follow-up of these studies, and should this be the case, explore and describe those issues. Our analysis is based on reviewing publications up to date which examine the clinical, research and other uses of LSD and those addressing ethical and methodological concerns of these applications, just as some historical examinations of this subject. The first chapters of the paper give an overview regarding the history of LSD-research with human participants, healthy volunteers and patients alike. The remaining chapters have a focus on questions regarding the potential ethical issues of such human trials in the contemporary research ethics framework. We also consider briefly political and regulatory issues regarding this substance that possibly affect its clinical and research applications.

Entities:  

Keywords:  Clinical trial; LSD research; Lysergic acid diethylamide; Psychedelic research; Research ethics

Mesh:

Substances:

Year:  2019        PMID: 30327902      PMCID: PMC6467737          DOI: 10.1007/s11019-018-9871-9

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  33 in total

1.  What makes clinical research ethical?

Authors:  E J Emanuel; D Wendler; C Grady
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

2.  Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials.

Authors:  Teri S Krebs; Pål-Ørjan Johansen
Journal:  J Psychopharmacol       Date:  2012-03-08       Impact factor: 4.153

3.  The response of normal men to lysergic acid derivatives (di- and monoethyl amides); correlation of personality and drug reactions.

Authors:  J M VON FELSINGER; L LASAGNA; H K BEECHER
Journal:  J Clin Exp Psychopathol       Date:  1956 Oct-Dec

4.  Drug harms in the UK: a multicriteria decision analysis.

Authors:  David J Nutt; Leslie A King; Lawrence D Phillips
Journal:  Lancet       Date:  2010-10-29       Impact factor: 79.321

5.  From LSD to the IRB: Henry Beecher's psychedelic research and the foundation of clinical ethics.

Authors:  George A Mashour
Journal:  Int Anesthesiol Clin       Date:  2007

6.  Efficacy and enlightenment: LSD psychotherapy and the Drug Amendments of 1962.

Authors:  Matthew Oram
Journal:  J Hist Med Allied Sci       Date:  2012-08-16       Impact factor: 2.088

Review 7.  From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.

Authors:  David E Smith; Glenn E Raswyck; Leigh Dickerson Davidson
Journal:  J Psychoactive Drugs       Date:  2014 Jan-Mar

Review 8.  Flashback: psychiatric experimentation with LSD in historical perspective.

Authors:  Erika Dyck
Journal:  Can J Psychiatry       Date:  2005-06       Impact factor: 4.356

9.  LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects.

Authors:  Peter Gasser; Katharina Kirchner; Torsten Passie
Journal:  J Psychopharmacol       Date:  2014-11-11       Impact factor: 4.153

Review 10.  The pharmacology of lysergic acid diethylamide: a review.

Authors:  Torsten Passie; John H Halpern; Dirk O Stichtenoth; Hinderk M Emrich; Annelie Hintzen
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.